Literature DB >> 8574055

Benefits of arterial reconstruction in claudication.

T Ohta1, R Kato, I Sugimoto, K Hida, J Hachiya, E Mihara, T Hasegawa, Y Imamura, H Ishibashi, M Hosaka.   

Abstract

We conducted a midterm follow-up of 150 claudicants who underwent surgical reconstruction by assessing cumulative patency, survival, and palliation (graft patency in live patients) rates. Eighty-nine claudicants (group I) underwent direct (in situ) proximal revascularization, 33 (group II) had indirect (ex situ) proximal revascularization, while 28 (group III) had distal revascularization. The secondary patency rates at 3 years were 97.5% in group I, 97.0% in group II, and 75.0% in group III, respectively. Only one patient with limb graft thrombosis required below-knee amputation. There were 3 perioperative deaths (2 in group I and 1 in group II). The survival rates at 3 years were 86.0% in group I, 69.5% in group II, and 95.8% in group III, respectively. The palliation rates at 3 years were 84.8% in group I, 70.0% in group II, and 77.9% in group III, respectively. These findings indicate the midterm benefits of supra- and infrainguinal arterial reconstructions, and also suggest that the preoperative assessment of risks in individual patients, the selection of the appropriate operative procedure and graft material, and intensive postoperative follow-up and management of any associated disease are all important aspects in the treatment of claudicants.

Entities:  

Mesh:

Year:  1995        PMID: 8574055     DOI: 10.1007/bf00311754

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Clinical results of femoropopliteal bypass using externally supported (EXS) Dacron grafts: with a comparison of above- and below-knee anastomosis.

Authors:  J Matsubara; M Nagasue; S Tsuchishima; B Nakatani; T Shimizu
Journal:  J Cardiovasc Surg (Torino)       Date:  1990 Nov-Dec       Impact factor: 1.888

2.  Femoropopliteal reconstruction for claudication. The risk to life and limb.

Authors:  K C Kent; M C Donaldson; C E Attinger; N P Couch; J A Mannick; A D Whittemore
Journal:  Arch Surg       Date:  1988-10

3.  Resurrection of the in situ saphenous vein bypass. 1000 cases later.

Authors:  R P Leather; D M Shah; B B Chang; J L Kaufman
Journal:  Ann Surg       Date:  1988-10       Impact factor: 12.969

4.  A five- to seven-year experience with externally-supported Dacron prostheses in axillofemoral and femoropopliteal bypass.

Authors:  G A Schultz; L R Sauvage; S R Mathisen; P B Mansfield; J C Smith; C C Davis; D G Hall; E A Rittenhouse; T E Kowalsky
Journal:  Ann Vasc Surg       Date:  1986-09       Impact factor: 1.466

5.  Prosthetic above-knee femoropopliteal bypass for intermittent claudication.

Authors:  D Rosenthal; R D Evans; J McKinsey; M A Seagraves; P A Lamis; M D Clark; W W Daniel
Journal:  J Cardiovasc Surg (Torino)       Date:  1990 Jul-Aug       Impact factor: 1.888

6.  Influence of distal arterial occlusive disease on prognosis following aortobifemoral bypass.

Authors:  B D Martinez; N R Hertzer; E G Beven
Journal:  Surgery       Date:  1980-12       Impact factor: 3.982

7.  Femorofemoral bypass grafts: ten-year experience.

Authors:  F R Plecha; F M Plecha
Journal:  J Vasc Surg       Date:  1984-07       Impact factor: 4.268

8.  Extra-anatomic bypass: a closer view.

Authors:  R B Rutherford; A Patt; W H Pearce
Journal:  J Vasc Surg       Date:  1987-11       Impact factor: 4.268

9.  Axillofemoral bypass: a tool with a limited role.

Authors:  M C Donaldson; J C Louras; C A Bucknam
Journal:  J Vasc Surg       Date:  1986-05       Impact factor: 4.268

10.  Aortic reconstruction vs extra-anatomic bypass and angioplasty. Thoughts on evolving a protocol for selection.

Authors:  T J Bunt
Journal:  Arch Surg       Date:  1986-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.